InvestLog
BLTE logo

BLTE

Belite Bio, IncNASDAQHealthcare
$169.85+0.78%ClosedMarket Cap: $6.68B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-03HC Wainwright & Co.—Buy—
2026-03-03Cantor Fitzgerald—Overweight—
2026-03-03Morgan Stanley—Overweight—
2026-01-28HC Wainwright & Co.—Buy—
2025-12-02Mizuho—Outperform—
2025-12-01HC Wainwright & Co.—Buy—
2025-10-31Benchmark—Buy—
2025-09-15HC Wainwright & Co.—Buy—
2025-07-03HC Wainwright & Co.—Buy—
2025-05-15Cantor Fitzgerald—Overweight—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$1.30$204.3M5
Sun Dec 31$8.66$563.2M4
Mon Dec 31$16.14$985.6M2
Tue Dec 31$22.07$1.41B2
BLTE | Belite Bio, Inc Analyst Ratings & Price Target - InvestLog